Table 2 Comparison of survival (BCSS, OS) in patients with and without adipose tissue invasion
ATI-negative | ATI-positive | ||||
|---|---|---|---|---|---|
Survival | Patient groups | No of events/No of patients | No of events/No of patients | Hazard ratio | P Value |
(%) | (%) | (95%CI) | |||
BCSS | All | 5/119 (4) | 89/609 (15) | 3.23 (1.31-7.95) | 0.01 |
OS | All | 10/119 (8) | 114/609 (19) | 2.1 (1.1-4.0) | 0.025 |
Age | |||||
< 70 | 5/91 (5) | 77/476 (16) | 2.69 (1.09-6.65) | 0.032 | |
> = 70 | 5/28 (18) | 37/133 (28) | 1.58 (0.62-4.04) | 0.337 | |
Menopausal status | |||||
Premenopausal | 1/38 (3) | 28/196 (14) | 5.32 (0.72-39.08) | 0.101 | |
Postmenopausal | 9/80 (11) | 81/401 (20) | 1.66 (0.83-3.31) | 0.149 | |
Lymph node involvement | |||||
Negative | 8/101 (8) | 41/355 (12) | 1.37 (0.64-2.91) | 0.423 | |
Positive | 1/13 (8) | 71/243 (29) | 3.66 (0.51-26.34) | 0.198 | |
Stage | |||||
I | 8/95 (8) | 25/265 (9) | 1.07 (0.48-2.37) | 0.874 | |
II | 1/14 (7) | 36/217 (17) | 1.61 (0.22-11.78) | 0.64 | |
III | 0/3 (0) | 49/108 (45) | – | – | |
Histologic grade | |||||
I, II | 6/62 (10) | 58/387 (15) | 1.45 (0.62-3.36) | 0.39 | |
III | 4/57 (7) | 54/212 (25) | 3.5 (1.27-9.67) | 0.016 | |